We investigated the neuroprotective effect of thioredoxin 1 (Trx1) and thioredoxin 2 (Trx2) which play critical roles in the regulation of oxidative stress on retinal ganglion cells (RGCs) in a rat glaucoma model. Expression of Trx1 and Trx2 and Trx-interacting protein (Txnip) was observed in the RGC layer (GCL), nerve fiber layer and inner nuclear layer. Txnip-, Trx1-and Trx2-expressing cells in the GCL were primarily colocalized with RGCs. The increased Txnip protein level was observed 2 and 5 weeks after glaucoma induction. Trx1 level decreased 2 weeks after glaucoma induction and more prominently after 5 weeks. No change in Trx2 levels was detected. The effects of Trx1 and Trx2 overexpression on RGC survival were evaluated 5 weeks after glaucoma induction. In nontransfected and EGFP-transfected (used as a negative control) retinas, RGC loss was approximately 27% compared with control. The loss of RGCs in Trx1-and Trx2-transfected retinas was approximately 15 and 17%, respectively. Thus, Trx1 and Trx2 preserved 45 and 37% of cells, respectively that were destined to die in glaucomatous retinas. The results of this study provide evidence for the involvement of oxidative stress in RGC degeneration in experimental glaucoma and point to potential strategies to reduce its impact.
Introduction
The degeneration of retinal ganglion cells (RGCs) and their axons in the optic nerve is the cause of visual deficits in glaucoma patients. [1] [2] [3] Chronic forms of the disease usually progress over many years. Currently, reduction of intraocular pressure (IOP) remains the main strategy to slow progression of the disease. In patients with normal pressure glaucoma, lowering IOP usually also has a positive effect. However, glaucomatous neuropathy often continues to progress even after IOP has been reduced, especially in advanced disease. It is clear that new strategies are required to supplement or perhaps replace IOP reduction in some patients to reduce the number of degenerating neurons and to preserve the surviving RGCs and their axons. Since the exact molecular pathways of RGC death are not understood, several avenues of RGC neuroprotection are being investigated, including blocking glutamate excitotoxicity, stabilizing Ca 2+ homeostasis, inhibiting nitric oxide production, supplying neurotrophins, enhancing the stress protein response, preventing apoptosis, improving blood flow to the optic nerve and modulating immunologic status by vaccination. [4] [5] [6] [7] [8] [9] [10] Oxidative stress has been implicated in a variety of neurodegenerative diseases such as Alzheimer's, Parkinson, Huntington's and amyotrophic lateral sclerosis. [11] [12] [13] [14] [15] [16] [17] Oxidative stress has also been proposed to be a common factor in RGC death during glaucomatous neurodegeneration and after optic nerve transection, tissue hypoxia, ischemia and axonal transport disruption. [18] [19] [20] Oxidative stress occurs when generation of reactive oxygen species (ROS) exceeds the ability of cells to neutralize and eliminate them. ROS excess can damage cellular constituents and initiate the apoptotic signaling pathway. 21, 22 Protection from ROS is mediated by superoxide dismutase, the glutathione and thioredoxin (Trx) systems. 23, 24 The Trx system is a ubiquitous thiol-reducing system that includes Trx, Trx-interacting protein (Txnip), Trx reductase (Trxr) and NADPH. 25, 26 Trx is a small (12 kDa) protein with a conserved active site Trp-Cys-Gly-Pro-Cys that plays an important defensive role against oxidative stress by scavenging intracellular ROS. Binding of ROS leads to Trx oxidation. Trxr in the presence of NADPH can convert oxidized Trx back to its reduced form. Trx proteins are represented in the cell by at least two forms; Trx1 is present in the cytoplasm and Trx2 is localized in the mitochondria. 27 Trx reducing activity and its expression is negatively regulated by Txnip. 28 As Txnip interaction with Trx involves Trx active site, other Trxbinding proteins will be competing with Txnip for binding. It has been shown, that overexpression of Txnip lessens Trx interaction with apoptosis signal-regulating kinase 1 (Ask-1), resulting in an increased sensitivity of cells to oxidative damage. 29 Trx function in the retina has been primarily associated with its cell protective effect against photooxidative damage to photoreceptors. 30, 31 Intravitreous injection of Trx was reported to inhibit oxidative stress and reduce NMDA-induced retinal cell damage. 32 Induction of the Trx1 was observed in the DBA/2J mouse retina in response to systemic injection of 17-b-estradiol. 33 In this study, we investigated the involvement of endogenous Txnip and Trx proteins in glaucomatous neurodegeneration and evaluated the neuroprotective effect of Trx1 and Trx2 overexpression in a rat glaucoma model.
Results

IOP elevation
Glaucoma was induced in adult Wistar rats (B3 months old, 250-300 g) by moderate, chronic IOP elevation. The IOP of the laser-treated eyes was compared to IOP of the contralateral eyes, which served as controls (Figure 1) . To determine the effect of electroporation (ELP), injection/ transfection/overexpression of EGFP, EGFP-Trx1 or EGFP-Trx2 on IOP level, the glaucoma group was compared with untreated control, glaucoma plus EGFP transfection group with EGFP transfection, glaucoma with Trx1 transfection group with Trx1 transfection and glaucoma with Trx2 transfection group with Trx2 transfection. Significant differences of IOP in the laser treatment group compared with the corresponding control were observed starting at 1 week after treatment. Increased IOP was sustained for 5 weeks, with a maximum of 32.1±7.7 mm Hg at 1 week. No significant impact of ELP, injection/transfection/overexpression of EGFP, Trx1 or Trx2 on IOP was observed.
Expression of Txnip and Trx1 and Trx2 in the retina
Immunohistochemistry was performed on untreated rat retinal sections to determine Txnip, Trx1 and Trx2 spatial expression (Figure 2 ). The distribution of Txnip, Trx1 and Trx2 expressions in the retina was similar. The most abundant expression of these proteins was observed in the RGC layer (GCL), nerve fiber layer (NFL) and inner nuclear layer (Figures 2a and b) . Furthermore, most Txnip-, Trx1-and Trx2-expressing cells in the GCL were colocalized with neurofilament-(NF, Figure 2a ) and Thy1 (Figure 2b )-positive cells, used as RGC markers.
The changes in Txnip and Trx1 and Trx2 expression levels induced by IOP elevation were analyzed in whole retinal extracts with immunoblotting ( Figure 3) . A significant increase (B1.5-fold) of Txnip expression was observed in retinas 2 (n ¼ 8, P ¼ 0.0063) and 5 (n ¼ 8, P ¼ 0.0016) weeks after IOP elevation compared with the control retina (Figures 3a-1 and b-1) . The Trx1 level appeared to decrease slightly at 2 weeks (n ¼ 8, P ¼ 0.011) and more prominently at 5 weeks (n ¼ The effect of Trx1 and Trx2 overexpression on RGC survival was evaluated 5 weeks after IOP elevation. In nontransfected retinas, the loss of RGCs was approximately 27% compared with the control (n ¼ 14 for control and n ¼ 5 for glaucoma, P ¼ 0.0011; Figures 5a-3 and c). Transfection with pEGFP, which was used as a negative control, had no significant effect on RGC survival compared with nontransfected eyes (Figures 5a-4 and c) . RGC loss in nontransfected retinas and in retinas transfected with pEGFP was correlated with peak IOP (Figure 1 -6 and c) transfected retinas was approximately 15 and 17%, respectively, compared with the control eyes. These results show that Trx1 and 2 preserved 45 and 37% of cells, respectively that were destined to die in glaucomatous retinas (n ¼ 5 for glaucoma+pEGFP, n ¼ 9 for glaucoma+pEGFP-Trx1, P ¼ 0.028, n ¼ 6 for glaucoma+pEGFP-Trx2, P ¼ 0.044). Neuroprotective
Discussion
Oxidative stress has been acknowledged as an important factor in ocular hypertension associated RGCs death. Decreased activity of several enzymes of the antioxidant defense system, including superoxide dismutase, glutathione peroxidase and catalase has been implicated in RGC death in rat retinas with experimental glaucoma. 34 In the current study, we have analyzed the cell protective effects of two redox Trx proteins, Trx1 and Trx2, in the glaucomatous rat retina. First, we have determined whether the levels of endogenous proteins, Trx1 and Trx2 and Txnip are modulated in response to IOP elevation. Immunoblot analysis showed significant increases in Txnip expression in 2-and 5-week glaucomatous retinas, compared with the controls. The Trx1 level, on the other hand, was slightly reduced at 2 weeks of experimental glaucoma. Trx1 downregulation was more evident in 5 week hypertensive retinas. No considerable IOP-induced changes were observed in Trx2 protein levels. Txnip is involved in redox regulation through interaction with the catalytic active center of Trx1 and downregulates its activity and expression. 28, 35 Thus, Txnip is considered as a negative regulator of Trx1 and redox. Modulation of Txnip and Trx1 levels in glaucomatous retinas observed in this study agree with the published data. IOP-induced upregulation of Txnip expression most likely is responsible for the reduction of Trx1 level. These changes in Txnip and Trx1 levels are particularly interesting, as Txnip and Trx1 are localized abundantly in nerve fiber layer and RGC somas, which are predominantly affected by IOP elevation.
Negative redox regulation by induced Txnip suggests two potential ways to protect cells against oxidative stress in our model: reduce the level of Txnip or upregulate Trx expression. In this study, we chose to overexpress both Trx1 and Trx2 in glaucomatous retinas to determine their roles in RGC survival. EGFP-fused Trx1 and Trx2 expression constructs were delivered to the retina by ELP. This method has been successfully used previously to transfect RGCs. [36] [37] [38] [39] Although ELP does not target RGCs specifically, and transfected cells were distributed not only in the GCL, but also in the inner nuclear layer; most of GCL transfected cells were colocalized with RGCs. We found that cells in the nasal superior or nasal inferior quadrants of the retina were transfected more efficiently than cells in other retinal regions. We believe that this is due to the positioning of the anodal needle electrode on the forehead. It is possible that the tweezer-type electrodes provide more even transfection across the retina as the anodal electrode is disk-shaped and placed directly on the optic nerve side of the sclera. However, ELP with lens-type and needle Neuroprotective role of thioredoxins in glaucoma Y Munemasa et al electrodes were given preference in these experiments, as this method is less invasive (no surgery is required) than transfection with tweezer-type electrodes. ELP settings were optimized to achieve high transfection efficiencies without damaging the tissue by using various electrical field strengths, pulse duration and stimulation patterns.
Overexpression of both Trx1 and Trx2 in glaucomatous retinas supported RGC survival. The loss of RGCs in pEGFP-Trx1 or pEGFP-Trx2 transfected retinas was approximately 15 and 17%, respectively, vs 27% in nontransfected or pEGFP transfected glaucomatous retinas. Thus, Trx1 and Trx2 preserved 45 and 37% of cells, respectively, that were destined to die in glaucomatous neurodegeneration. It is likely that the cell protective effect of Trx1 and 2 observed in this study could be even higher considering RGC transfection efficiency by Trx-expression constructs was approximately 42-44%. As oxidative stress-induced dysfunction of glial cells has been proposed to play a role in secondary neuronal damage in glaucoma, 19, 40 transfection with Trx1 and Trx2 may reduce the impact of oxidative stress in these cells and thus contribute to RGC survival. In this study, approximately 30% of Trx1-and 32% of Trx2-transfected cells were non-RGCs, including glial cells. As stated above, the neuroprotective effect of Trx proteins was observed in glaucomatous retinas 5 weeks after IOP elevation. Further studies are necessary to determine the persistence of the effect of these proteins on RGC survival beyond this time point.
Trx proteins play important roles in defense against oxidative stress and perform a variety of biological functions, including regulation of apoptotic cell death.
41
Trx1 is known to act as a negative regulator of the Ask1-Jnk/p38 apoptotic pathway. 42, 43 In resting cells, Trx1 directly binds and inhibits the kinase activity of homooligomerized apoptosis signal-regulating kinase 1 (Ask1), which plays pivotal roles in ROS-induced cellular responses. 42 Upon oxidative stress, Trx1 dissociates from the Ask1 and Ask1 forms a fully activated complex by recruitment of tumor necrosis factor receptor-associated factor 2 (TRAF2) and TRAF6.
While Trx1 together with Trx1 reductase and peroxiredoxin are critical components of the Trx system in the cytosol, Trx2, Trx2 reductase and peroxiredoxin 3 constitute a redox-reducing system in mitochondria. 44 The production of ROS in mitochondria is strictly regulated by mitochondrial antioxidant systems and the Trx2 system has been shown to be essential for cell viability. 45 Trx2 deficient cells undergo apoptosis that involves accumulation of intracellular ROS, release of cytochrome c into the cytosol and activation of caspases 3 and 9. 45 Massive apoptosis and early embryonic death in Trx2-deficient mice demonstrate a crucial role for Trx2 in cell survival. 46 The antiapoptotic characteristics of Trx2 were associated with its roles in regulation of mitochondrial outer membrane permeability and the levels of proapoptotic Bcl-xL. 47 In summary, changes in Txnip and Trx1 levels after IOP elevation implicate these redox proteins in the RGC degenerative process in glaucomatous retinas. Txnip, Trx1 and Trx2 are shown to be abundantly expressed in RGC somas and nerve fiber layer. Overexpression of cytosolic Trx1 and mitochondrial Trx2 in ocular hypertensive retinas has a protective effect on RGCs against glaucomatous neurodegeneration. The results of this study provide evidence for involvement of oxidative stress in RGC degeneration in experimental glaucoma and point to potential strategies to reduce its impact.
Materials and methods
Animals
The use of animals for this study was approved by the Animal Research Committee of the University of California, Los Angeles, and was performed in compliance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research. Male Wistar rats weighting 250-300 g were housed with standard food and water provided ad libitum. The animal room was lit with fluorescent lights (330 lux) automatically turned on at 0300 h and off at 1500 h, and the temperature was kept at 21 1C.
Rat glaucoma model and measurements of IOP
The animals were maintained for at least 1 week before surgical procedures. A rat glaucoma model was generated as described previously. 7 Briefly, rats anesthetized by inhalation of isofluorane (1.5-3.5%) in oxygen were injected intracamerally with 10 ml of 35% India ink (Becton Dickinson, Cockeysville, MD, USA) in 0.01 M phosphate buffer saline (PBS) after removing the same volume of aqueous, and Tobrex ophthalmic ointment (Tobramycin; Alcon, Fort Worth, TX, USA) was applied topically. A dark circumferential band at the limbus was noted in the trabecular meshwork due to the aggregation of carbon particles 5 days after injection. Approximately 200 laser burns were delivered ab externo to the pigmented trabecular band at dye laser setting of 532 lm, 200 mm diameter, 150-200 mW and 0.2 s duration (Novus Spectra, Lumenis, Santa Clara, CA, USA). Two weeks after the first laser treatment, second trabecular laser photocoagulation was performed without further injection of ink.
Dark-phase IOP measurements were monitored once a week with a portable tonometer (Tonolab, Tiolat, Helsinki, Finland). IOP measurements were performed in animals in the awake state 1 h after initiation of the dark phase. 48 Following topical instillation of 0.5% proparacaine hydrochloride (Alcaine; Alcon), the tonometer was gently and briefly applied to the cornea and IOP readings were recorded. Five consecutive readings were taken. After eliminating the minimum and maximum measurements, three readings were averaged.
Immunoblot analysis
Each freshly dissected retina was homogenized separately by ultrasonic disruption in a lysis buffer (50 mM phosphate buffer, 0.25 M sucrose, 0.1 mg ml À1 phenylmethylsulfonyl fluoride (PMSF) in isopropanol, and 30 mg ml À1 aprotinin). Protein concentration was determined by using a BCA Protein Assay Kit (Pierce, Rockford, IL, USA). Immunoblot analysis was carried out as described previously. 49, 50 Briefly, 2-5 mg of protein was separated on a 12.5% SDS-polyacrylamide gel and transferred to the polyvinylidene membrane (Millipore, Bedford, MA, USA). After blocking with 5% nonfat milk, the membranes were incubated with primary polyclonal antibodies against Txnip (Zymed Laboratories, San 
Immunohistochemistry
Animals were deeply anesthetized with intramuscular injections of 0.8 ml kg À1 of a cocktail containing ketamine (100 mg ml À1 ), 1.0 ml aceptomazine (10 mg ml À1 ) and 1.5 ml normal saline and transcardially perfused with 4% paraformaldehyde in 0.1 M phosphate buffer. The enucleated eyes were immersed in fixative for 1 h, bisected and post-fixed for 3 h. Eyecups were incubated with 30% sucrose at 4 1C overnight and embedded in OCT compound (Sakura Finetec, Torrance, CA, USA). The 10-mm thick sections were obtained along the vertical meridian through the optic nerve head. The sections were washed three times with PBS in Triton-X (T-PBS) for 5 min and incubated with blocking buffer (T-PBS containing 5% bovine serum albumin) at room temperature for 30 min. After blocking, they were incubated with primary antibodies at 4 1C overnight. The primary antibodies recognizing the following proteins were used in this study: Txnip and Trx1 and Trx2, GFP (Chemicon), NF (Chemicon), calbindin (Chemicon), Thy-1 (Chemicon) and GFAP (Calbiochem, La Jolla, CA, USA). GFP antibodies were used to amplify the EGFP signal after ELP. NF, calbindin and GFAP antibodies were used to distinguish RGCs, amacrine cells and astrocytes, respectively. Following incubation with the primary antibodies, sections were incubated with rhodamine-conjugated antirabbit immunoglobulin G antibody or FITC-conjugated antimouse immunoglobulin G antibody (Cappel Research Products, Durham, NC, USA) at room temperature for 60 min. After mounting with antifade mounting solution, photomicrographs of the sections at 1.0-1.5 mm from the center of the optic nerve were taken with a fluorescence microscope Axiovert 135 M equipped with a LSM410 confocal system (Carl Zeiss, Oberkochen, Germany). Negative-control sections were incubated without primary antibodies. DAPI (4 0 ,6-diamino-2-phenylindole dihydrochloride; Molecular Probes, Eugen, OR, USA) was used for nuclear staining. The distribution of EGFP-positive cells was analyzed with fluorescence microscopy.
Gene transfer into RGCs with electroporation
EGFP-tagged Trx1 and Trx2 expression constructs, pEGFP-C1-Trx1 51 and pCMV-hTrx2-EGFP, 47 were delivered to retinal cells by ELP 1 day before laser photocoagulation. Transcription of the Trx genes in both vectors is controlled by CMV (cytomegalovirus) promoter. Expression of functional Trx proteins from these constructs was analyzed earlier in the retina, RGC-5 and K-1034 cells. 51, 52 ELP-mediated gene delivery was performed as described previously with minor modifications. 37, 39 In brief, animals were anesthetized with an intramuscular injection of 0.8 ml kg À1 of a cocktail containing 5 ml ketamine (100 mg ml À1 ), 2.5 ml xylazine (20 mg ml À1 ), 1.0 ml acepromazine (10 mg ml À1 ), and 1.5 ml normal saline. Four microliters of plasmid DNA (20 mg) was injected into the vitreous cavity with a 34-gauge needle 0.5 mm posterior to the limbus under stereoscopic microscopy. After 10 min, the cathodal electrode was placed on the cornea, and an 18-gauge needle with an attached anodal needle electrode was placed subcutaneously at the middle of the forehead. Electric pulses were generated by an ECM 830 Pulse Generator (BTX, San Diego, CA, USA). The parameters were as follows: electric field strength 6 V/cm, pulse duration 100 ms and stimulation pattern of five pulses at a frequency of one pulse per second. After a 10 min pause, five more pulses with the same parameters were delivered.
RGC counting
The number of remaining RGCs was determined 5 weeks after IOP elevation. Retrograde labeling of RGCs was performed 48 h before animals were killed by applying dye to the proximal cut surface of the axotomized optic nerve, as described previously with minor modifications. 7 Animals were anesthetized by inhalation of isoflurane (1.5-3.5%) in oxygen, the optic nerve was exposed through a lateral conjunctival incision, and the optic nerve sheath was incised with a needle knife 2 mm longitudinally, starting 3 mm behind the globe. A small piece of gelfoam soaked with DTMR (Molecular Probes) was applied to the proximal cut surface of the optic nerve. The eyes were enucleated and immersed in 4% paraformaldehyde in 0.1 M phosphate buffer for 1 h. The retinas were dissected from the eyeballs and mounted on glass slides with four radial cuts (superotemporal, inferotemporal, superonasal, and inferonasal).The RGCs were counted at 1, 2 and 3 mm from the center of the optic nerve in retinal quadrant under fluorescent microscopy at Â 200 magnification. Quantification was performed in a masked manner. This method of RGC labeling has been commonly used to quantify these cells, and although some RGCs may degenerate immediately after axotomy, a number of studies have observed virtually no RGC loss during first 3-4 days after the surgery. [52] [53] [54] [55] As in this study, RGCs were counted 2 days after axotomy, we believe that the effect of this procedure on the RGC numbers at that time is not significant.
Statistical analysis
Data are presented as the mean ± s.d. Differences among groups were analyzed by one-way analysis of variance, followed by the Scheffé or Mann-Whitney test. Po0.05 was considered statistically significant.
